Der Anaesthesist

, Volume 56, Issue 8, pp 765–771 | Cite as

„Bedside“-Thrombelastographie

Kostenreduktion in der Herzchirurgie
  • G.J. Spalding
  • M. Hartrumpf
  • T. Sierig
  • N. Oesberg
  • C.G. Kirschke
  • J.M. Albes
Originalien

Zusammenfassung

Hintergrund

Demographische Änderungen und aggressive Medikation mit Thrombozytenaggregationshemmern haben einen erheblichen Anstieg der Kosten des Blut- und Blutprodukteverbrauchs in der Herzchirurgie nach sich gezogen. Um einen kosteneffizienten Behandlungspfad zu generieren, wurde die Qualität der Gerinnselbildung mithilfe der „Bedside“-Rotationsthrombelastographie (ROTEM) evaluiert.

Patienten und Methoden

Die Behandlungskosten von herzchirurgischen Patienten wurden retrospektiv vor (729 Patienten) und nach (693 Patienten) Implementierung des Bedside-ROTEM analysiert. Kumulative Zahlen und Kosten von Thrombozytenkonzentraten (TK), Fresh Frozen Plasma (FFP), Erythrozytenkonzentraten (EK) und den Gerinnungsfaktoren: Prothrombinkomplexkonzentrat, rekombinanter Faktor VIIa (NovoSeven®), Faktor XIII (Fibrogammin®) und Fibrinogen (Hämocomplettan®) wurden erfasst. Durchschnittliche monatliche Zahlen und Kosten wurden verglichen. Die Anzahl der Rethorakotomien und die Frühletalität wurden in beiden Perioden erhoben und gegenübergestellt.

Ergebnisse

Nach ROTEM-Implementierung sanken der kumulative EK-Verbrauch um 25% und der TK-Verbrauch um 50%. Der FFP-Verbrauch änderte sich hingegen nicht. Prothrombinkomplexkonzentrat und Fibrogammin® wurden zu 80% weniger eingesetzt; auf NovoSeven® konnte gänzlich verzichtet werden. Der Hämocomplettan®-Verbrauch verdoppelte sich. Die kumulativen monatlichen Kosten aller Blutprodukte sanken von 66.000 EUR auf 45.000 EUR (−32%). Die monatlichen Kosten für Gerinnungsfaktoren verringerten sich von 60.000 EUR auf 30.000 EUR (−50%), sodass sich eine kombinierte Ersparnis von 44% ergab. Im Gegensatz dazu beliefen sich die monatlichen Kosten für ROTEM auf 1580 EUR. Die Gesamtzahl der Rethorakotomien sank von 6,6 auf 5,5%, während die Frühletalität (5,9%, 6,0%) stabil blieb.

Zusammenfassung

Die kumulativen Kosten für die Behandlung von perioperativen Gerinnungsstörungen wurden durch ein selektives Substitutionsmanagement unter Zuhilfenahme von Bedside-ROTEM erheblich gemindert. Die eingesparten Kosten für Blut- und Gerinnungsprodukte kompensierten dabei klar die Aufwendungen für das ROTEM. Ein adäquates differenziertes Gerinnungsmanagement kann daher durchaus kosteneffizient sein.

Schlüsselwörter

Herzchirurgie Kostenreduktion Gerinnungsmanagement Blutproduktverbrauch Rotationsthrombelastographie 

Bedside thrombelastography

Cost reduction in cardiac surgery

Abstract

Background

Demographic changes and aggressive medication with platelet aggregation inhibitors have resulted in a marked increase in blood and coagulation product expenditure and costs in cardiac surgery. We analyzed the bedside coagulation test (ROTEM) in order to verify clot forming quality and to find a cost-effective treatment algorithm.

Patients and methods

Annual treatment costs of all cardiosurgical patients were retrospectively analyzed before (729 patients) and after (693 patients) implementation of the bedside ROTEM test. Cumulative numbers and costs of platelet concentrates (PltC), fresh frozen plasma (FFP), red blood cell units (RBC), and the coagulation factors prothrombin complex concentrates (PCC), recombinant factor VIIa (rFVIIa), factor XIII (FXIII), and fibrinogen were assessed. Average monthly numbers and costs were compared. The number of rethoracotomies and early mortality were assessed and compared in both periods.

Results

After ROTEM implementation cumulative RBC expenditure showed a 25% decrease and PltC a 50% decrease. FFP expenditure remained unchanged. PCC, FXIII were markedly reduced (-80%) while rFVIIa was entirely omitted. Fibrinogen, however, showed a two-fold increase. Cumulative average monthly costs of all blood products decreased from 66,000 EUR to 45,000 EUR (–32%). Coagulation factor average monthly costs decreased from 60,000 EUR to 30,000 EUR (–50%) yielding combined savings of 44%. In contrast, average monthly costs for ROTEM were 1,580 EUR. The total number of rethoracotomies decreased from 6.6% to 5.5% while early mortality (5.9%; 6.0%) remained stable.

Conclusions

Cumulative costs for treatment of perioperative coagulation disorders were reduced by bedside ROTEM analysis to achieve a selective substitution management. Saved costs for blood and coagulation products clearly outweighed the expenses of ROTEM. Adequate differential coagulation management can therefore be cost-effective.

Keywords

Cardiac surgery Cost reduction Coagulation management Blood product consumption Rotational thrombelastography 

Literatur

  1. 1.
    Goldman SM, Sutter FP, Wertan MA et al. (2006) Outcome improvement and cost reduction in an increasingly morbid cardiac surgery population. Semin Cardiothorac Vasc Anesth 10: 171–175PubMedCrossRefGoogle Scholar
  2. 2.
    Shore-Lesserson L, Manspeizer HE, DePerio M et al. (1999) Thrombelastography-guided transfusion algorithm reduces transfusion in complex cardiac surgery. Anesth Analg 88: 312–319PubMedCrossRefGoogle Scholar
  3. 3.
    Jennings LK (2005) Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes. Expert Opin Drug Metab Toxicol 1: 727–737PubMedCrossRefGoogle Scholar
  4. 4.
    DeAnda A Jr, Baker KM, Roseff SD et al. (2006) Developing a blood conservation program in cardiac surgery. Am J Med Qual 21: 230–237PubMedCrossRefGoogle Scholar
  5. 5.
    Anderson L, Quasim I, Soutar R et al. (2006) An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 16: 31–39PubMedCrossRefGoogle Scholar
  6. 6.
    Albes JM, Stohr IM, Kaluza M et al. (2003) Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating. J Thorac Cardiovasc Surg 126: 1504–1512PubMedCrossRefGoogle Scholar
  7. 7.
    Wippermann J, Albes JM, Hartrumpf M et al. (2005) Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system. Eur J Cardiothorac Surg 28: 127–132PubMedCrossRefGoogle Scholar
  8. 8.
    Heymann C von, Redlich U, Moritz M et al. (2005) Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss. Thorac Cardiovasc Surg 53: 341–345CrossRefGoogle Scholar
  9. 9.
    Yan BP, Gurvitch R, Ajani AE (2006) Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation. Cardiovasc Revasc Med 7: 155–158PubMedCrossRefGoogle Scholar
  10. 10.
    Braunwald E, Antman EM, Beasley JW et al. (2002) ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction – 2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 106: 1893–1900PubMedCrossRefGoogle Scholar
  11. 11.
    Drury NE, Nashef SA (2006) Outcomes of cardiac surgery in the elderly. Expert Rev Cardiovasc Ther 4: 535–542PubMedCrossRefGoogle Scholar
  12. 12.
    Angiolillo DJ, Bernardo E, Ramirez C et al. (2006) Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment. J Am Coll Cardiol 48: 298–304; Epub 2006 Jun 22PubMedCrossRefGoogle Scholar
  13. 13.
    Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T (2006) Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke 37: 2165–2167; Epub 2006 Jun 29PubMedCrossRefGoogle Scholar
  14. 14.
    Yan RT, Yan AT, Tan M et al. (2006) Age-related differences in the management and outcome of patients with acute coronary syndromes. Am Heart J 151: 352–359PubMedCrossRefGoogle Scholar
  15. 15.
    Lee LY, DeBois W, Krieger KH et al. (2002) The effects of platelet inhibitors on blood use in cardiac surgery. Perfusion 17: 33–37PubMedCrossRefGoogle Scholar
  16. 16.
    Eichert I, Isgro F, Kiessling AH, Saggau W (2001) Cell saver, ultrafiltration and direct transfusion: comparative study of three blood processing techniques. Thorac Cardiovasc Surg 49: 149–152PubMedCrossRefGoogle Scholar
  17. 17.
    Nuttall GA, Oliver WC, Ereth MH et al. (2000) Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding. Anesthesiology 92: 674–682PubMedCrossRefGoogle Scholar
  18. 18.
    Cross MH (2001) Autotransfusion in cardiac surgery. Perfusion 16: 391–400PubMedCrossRefGoogle Scholar
  19. 19.
    Penta de Peppo A, Pierri MD, Scafuri A et al. (1995) Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs. Tex Heart Inst J 22: 231–236Google Scholar
  20. 20.
    Dilthey G, Dietrich W, Spannagl M, Richter JA (1993) Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. J Cardiothorac Vasc Anesth 7: 425–430PubMedCrossRefGoogle Scholar
  21. 21.
    Wong BI, McLean RF, Fremes SE et al. (2000) Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. Ann Thorac Surg 69: 808–816PubMedCrossRefGoogle Scholar
  22. 22.
    Aljassim O, Karlsson M, Wiklund L et al. (2006) Inflammatory response and platelet activation after off-pump coronary artery bypass surgery. Scand Cardiovasc J 40: 43–48PubMedCrossRefGoogle Scholar
  23. 23.
    Raja SG, Dreyfus GD (2006) Impact of off-pump coronary artery bypass surgery on postoperative bleeding: current best available evidence. J Card Surg 21: 35–41; discussion 42–43PubMedCrossRefGoogle Scholar
  24. 24.
    Durand M, Chavanon O, Tessier Y et al. (2006) Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery. J Card Surg 21: 17–21PubMedCrossRefGoogle Scholar
  25. 25.
    Ritzwoller DP, Goodman MJ, Maciosek MV et al. (2005) Creating standard cost measures across integrated health care delivery systems. J Natl Cancer Inst Monogr 35: 80–87PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag 2007

Authors and Affiliations

  • G.J. Spalding
    • 1
  • M. Hartrumpf
    • 1
  • T. Sierig
    • 2
  • N. Oesberg
    • 2
  • C.G. Kirschke
    • 2
  • J.M. Albes
    • 1
  1. 1.HerzchirurgieHerzzentrum BrandenburgBernau bei BerlinDeutschland
  2. 2.Anaesthesiologie und IntensivtherapieHerzzentrum BrandenburgBernau bei BerlinDeutschland

Personalised recommendations